Document Details
Form
Filing Date
Mar 24, 2026
Document Date
Mar 20, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioCryst Pharmaceuticals, Inc.
Issuer
BIOCRYST PHARMACEUTICALS INC
Filer
HEGGIE THERESA